-
1
-
-
0026666542
-
2 receptor antagonist
-
2 receptor antagonist. J Pharmacol Exp Ther. 262: 759-768, 1992.
-
(1992)
J Pharmacol Exp Ther.
, vol.262
, pp. 759-768
-
-
Rinaldi-Carmona, M.1
Congy, C.2
Santucci, V.3
Simiand, J.4
Gautret, B.5
Neliat, G.6
Labeeuw, B.7
Lefur, G.8
Soubrie, P.9
Breliere, J.C.10
-
2
-
-
0019916099
-
Platelet mediated vascular contraction. Inhibition of the serotoninergic component by ketanserin
-
DE CLERCK, F., VAN NUETEN J. Platelet mediated vascular contraction. Inhibition of the serotoninergic component by ketanserin. Thromb Res 27: 713-27, 1982.
-
(1982)
Thromb Res
, vol.27
, pp. 713-727
-
-
De Clerck, F.1
Van Nueten, J.2
-
3
-
-
0021674879
-
Platelet-vessel wall interactions in hemostasis: Implication of 5-hydroxytryptamine
-
DE CLERCK, F., SOMERS, Y., VAN GROP, L. Platelet-vessel wall interactions in hemostasis: implication of 5-hydroxytryptamine. Agents Actions 15: 627-35, 1984.
-
(1984)
Agents Actions
, vol.15
, pp. 627-635
-
-
De Clerck, F.1
Somers, Y.2
Van Grop, L.3
-
4
-
-
0010393224
-
Platelets and coagulation
-
MAC INTYRE DE, GORDON JL (eds). Elsevier, Amsterdam
-
BEVERS, E.M., ROSING, J., ZWAAL, RFN. Platelets and coagulation. In: Platelets in Biology and Pathology III. MAC INTYRE DE, GORDON JL (eds). Elsevier, Amsterdam 1987; pp 127-60.
-
(1987)
Platelets in Biology and Pathology
, vol.3
, pp. 127-160
-
-
Bevers, E.M.1
Rosing, J.2
Zwaal, R.F.N.3
-
6
-
-
0342850956
-
Does the serotonin antagonist ketanserin have vascular protective effects?
-
Paoletti R, PM Vanhoutte, N Brunello, FM Maggi, eds. Dordrecht: Kluwer Academic
-
SYMOENS, J., DE CLERCK, F. Does the serotonin antagonist ketanserin have vascular protective effects? In: Paoletti R, PM Vanhoutte, N Brunello, FM Maggi, eds. Serotonin: from cell biology to therapeutics. Dordrecht: Kluwer Academic, pp 141-6, 1990.
-
(1990)
Serotonin: From Cell Biology to Therapeutics
, pp. 141-146
-
-
Symoens, J.1
De Clerck, F.2
-
7
-
-
0024348654
-
Prevention of atherosclerosis complications with ketanserin. Results of a large interventional trial
-
JANSSEN, M, SIMOENA J. Prevention of atherosclerosis complications with ketanserin. Results of a large interventional trial. IDR J Drug Ther Res 14: 138-144, 1989.
-
(1989)
IDR J Drug Ther Res
, vol.14
, pp. 138-144
-
-
Janssen, M.1
Simoena, J.2
-
10
-
-
0022975595
-
Modulation of smooth muscle responses by serine proteases and related enzymes
-
FAREED, J., KINDEL, G., and KUMAR, A. Modulation of smooth muscle responses by serine proteases and related enzymes. Semin Thromb. Hemost. 12: 265-76, 1986.
-
(1986)
Semin Thromb. Hemost.
, vol.12
, pp. 265-276
-
-
Fareed, J.1
Kindel, G.2
Kumar, A.3
-
11
-
-
0019123929
-
The role of platelets in acute vascular events
-
HARKER, L.A., RITCHIE, J.L. The role of platelets in acute vascular events. Circulation 13: 62, 1980.
-
(1980)
Circulation
, vol.13
, pp. 62
-
-
Harker, L.A.1
Ritchie, J.L.2
-
12
-
-
0022981606
-
Role of platelet activation and fibrin formation in thrombogenesis
-
VERMYLEN, J., VERSTRAETE, M., FUSTER, V. Role of platelet activation and fibrin formation in thrombogenesis. J. Am. Coll. Cardiol. 8: 2B-9B, 1986.
-
(1986)
J. Am. Coll. Cardiol.
, vol.8
-
-
Vermylen, J.1
Verstraete, M.2
Fuster, V.3
-
13
-
-
0022384824
-
Platelets, endothelium and vasospasm
-
VANHOUTTE PM, HOUSTON DS. Platelets, endothelium and vasospasm. Circulation 72: 728-34, 1985.
-
(1985)
Circulation
, vol.72
, pp. 728-734
-
-
Vanhoutte, P.M.1
Houston, D.S.2
-
15
-
-
0026048164
-
Serotonin and thrombotic complications
-
WILLERSON, J.T. Serotonin and thrombotic complications. J. Cardiovasc Pharmacol 17: S13-S20, 1990.
-
(1990)
J. Cardiovasc Pharmacol
, vol.17
-
-
Willerson, J.T.1
-
17
-
-
0018384177
-
Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets
-
DA PRADA, M., PICOTTI, G.B. Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets. Br J Pharmacol. 65: 653-62. 1979.
-
(1979)
Br J Pharmacol.
, vol.65
, pp. 653-662
-
-
Da Prada, M.1
Picotti, G.B.2
-
19
-
-
0025054331
-
Effect of ritanserin, a 5-hydroxytryptamine 2-receptor antagonist, on platelet function and thrombin generation at the site of plug formation in vivo
-
WAGNER, B., SCHNEIDER, B., BLOCHL-DAUM, B., SPEISER, W., EICHLER, H.G., LECHNER, K., KYRLE, P.A. Effect of ritanserin, a 5-hydroxytryptamine 2-receptor antagonist, on platelet function and thrombin generation at the site of plug formation in vivo. Clin Pharmacol Ther. 48: 419-23, 1990.
-
(1990)
Clin Pharmacol Ther.
, vol.48
, pp. 419-423
-
-
Wagner, B.1
Schneider, B.2
Blochl-Daum, B.3
Speiser, W.4
Eichler, H.G.5
Lechner, K.6
Kyrle, P.A.7
|